|Product Name||Maitake Extract|
|Latin Name||Grifola frondosa|
|Color||Brown yellow fine powder|
|Test method||UV / TLC|
|Particle Size||100% pass 80 mesh|
|Loss on Drying||≤5%|
|Storage||In cool & dry place.Keep away from strong light and heat|
|Shelf life||2 years when properly stored|
The fungus is native to China, the northeastern part of Japan and North America, and is prized in traditional Chinese and Japanese herbology as a medicinal mushroom.
In 2009, a phase I/II human trial, conducted by Memorial Sloan–Kettering Cancer Center, showed Maitake could stimulate the immune systems of breast cancer patients.
Small experiments with human cancer patients have shown Maitake can stimulate immune system cells, like NK cells.
In vitro research has also shown Maitake can stimulate immune system cells. An in vivo experiment showed that Maitake could stimulate both the innate immune system and adaptive immune system.
In vitro research has shown Maitake can induce apoptosis in various cancer cell lines as well as inhibit the growth of various types of cancer cells. Small studies with human cancer patients revealed that a portion of the Maitake mushroom, known as the Maitake D-fraction, possesses anti-cancer activity. In vitro research demonstrated the mushroom has potential anti-metastatic properties.
Research has shown Maitake has a hypoglycemic effect, and may be beneficial for the management of diabetes. The reason Maitake lowers blood sugar is because the mushroom naturally contains an alpha glucosidase inhibitor.
Maitake contains antioxidants and may partially inhibit the enzyme cyclooxygenase.